The World Federation of hemophilia: 40 years of improving haemophilia care worldwide

Haemophilia

Volumn 9, Issue 6, 2003, Pages 663-669

  Jones, Peter ^a   Robillard, Line ^a  

^a WORLD FEDERATION OF HEMOPHILIA   (Canada)

Author keywords

AIDS; Global Alliance for Progress; Haemophilia; Treatment centres; Twinning; World congress

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANADA; DEVELOPING COUNTRY; EDUCATION PROGRAM; FORECASTING; HEALTH; HEALTH CARE NEED; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH SERVICES RESEARCH; HEMOPHILIA; HEMOPHILIA A; HUMAN; INTERNATIONAL COOPERATION; MEDICAL EDUCATION; MEDICAL EXPERT; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDICAL STAFF; MONITORING; NON PROFIT ORGANIZATION; PARAMEDICAL PERSONNEL; PATIENT CARE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TREATMENT PLANNING; WORKSHOP; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CONGRESSES; DEVELOPING COUNTRIES; FORECASTING; HEMOPHILIA A; HUMANS; INTERNATIONAL COOPERATION; NEEDS ASSESSMENT; QUALITY OF HEALTH CARE; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 0348218232     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1351-8216.2003.00831.x     Document Type: Review

References (27)

1. Prevention and Control of Hemophilia: Memorandum from a Joint WHO/WFH Meeting (March 1990). Bull World Health Organ 1991; 69: 17-26.
2. Report of a Joint WHO/WFH Meeting on the Control of Hemophilia: Carrier Detection and Prenatal Diagnosis. Blood Coagul Fibrinolysis 1993; 4: 313-344.
3. Report of a Joint WHO/WFH Meeting on the Control of Hemophilia: Hemophilia Care in Developing Countries. Geneva: WHO, 1998.
4. Report of a Joint WHO/WFH Meeting on the Control of Hemophilia: Modern Treatment of Hemophilia. Geneva: WHO, 1994.
5. Report of a Joint WHO/WFH/ISTH Meeting: Delivery of Treatment for Hemophilia. London, United Kingdom, 11-13 February 2002. Geneva: WHO, 2002.
6. Berry E, Hilgartner M, Mariani G et al. Hemophilia: Facts for Families, Revised Edition. Geneva: WHO and WFH, 1996.
7. Berry E, Hilgartner M, Mariani G et al. Hemophilia: Facts for Healthcare Professionals, Revised Edition. Geneva: WHO and WFH, 1996.
8. Jones P, Boulyjenkov V. Guidelines for the Development of a National Programme for Hemophilia. Geneva: WHO and WFH, 1996.
9. Jones PM, Boulyjenkov V, eds. Hemophilia Care in Developing Countries. Hemophilia 1998; 4(Suppl. 2).
10. Rickard K. The International Hemophilia Training Centres of the World Federation of Hemophilia: A 30-year Review. Occasional Papers Monograph Series, No. 2. Montreal: WFH, 2001.
11. Isarangkura P, Chiewsilp P, Tanprasert S, Nuchprayoon C. Transmission of HIV infection by seronegative blood in Thailand. J Med Assoc Thai 1993; 76 (Suppl. 2): 106-113.
12. Chuansumrit A, Goodeve A, Sasanakul W et al. DNA Polymorphisms for carrier detection of hemophilia in Thailand. Southeast Asian J Trop Med Public Health 1995; 26 (Suppl. 1): 201-206.
13. Isarangkura P, Chiewsilp P, Chuansumrit A et al. Locally prepared fibrin glue for clinical application: reported of 145 cases. In: Tanin Intragumtornchai, eds. Hematology Trends 1998. Bangkok: Beyond Enterprises 1998: 13-25.
14. Jason JM, Evatt BL, Chorba TL, Ramsey RB. Acquired immunodeficiency syndrome (AIDS) in hemophiliacs. Scand J Haematol 1984; 33 (Suppl. 40): 349-356.
15. Status of Financial Assistance for HCV-infected Persons with Hemophilia in WFH Member Countries. Munich, Germany: WFH Information Clearinghouse, 2000.
16. Hemophilia Statistics: 1998 Survey. Munich, Germany: WFH Information Clearinghouse, 2000.
17. HIV Infection/AIDS Surveys in Hemophilia. Munich, Germany: WFH Information Clearinghouse, 1992-1996.
18. Schnabel M, Etzler J, eds. Status and Atlas of Hemophilia Worldwide. Munich, Germany: WFH Information Clearinghouse, 1984.
19. AIDS Center News. Los Angeles, CA: World Hemophilia AIDS Center, 1984-1986.
20. Hemophilia World. Los Angeles, CA: World Hemophilia AIDS Center, 1986-1994.
21. Farrugia A. Guide for the Assessment of Clotting Factor Concentrates for the Treatment of Hemophilia. Montréal, Canada: World Federation of Hemophilia 2003.
22. Proceedings of the WFH Global Forum on the Safety and Supply of Hemophilia Treatment Products. Montréal, Canada: World Federation of Hemophilia, 2000, 2002.
23. Evatt B, Giangrande P. Blood Transfusion and the Risk of New Variant Creutzfeldt-Jakob Disease (nvCJD). WFH Task Force on TSEs Bulletin 1. Montréal, Canada: World Federation of Hemophilia, 2000.
24. Farrugia A. Variant Creutzfeldt-Jakob Disease and Hemophilia: A Risk Assessment of Plasma-derived Products. WFH Task Force on TSEs Bulletin 2. Montréal, Canada: World Federation of Hemophilia, 2000, revised 2001.
25. Farrugia A. Donor Deferral Measures. WFH Task Force on TSEs Bulletin 3. Montréal, Canada: World Federation of Hemophilia, 2001.
26. Monographs of the Treatment of Hemophilia series are accessible from the WFH web site at http://www.wfh.org, under Publications/Library, or can be ordered from WFH headquarters at 1425 René Lévesque Boulevard West, Suite 1010, Montréal, Québec, H3G 1T7, Canada. Tel.: +1 (514) 875-7944; fax: +1 (514) 875-8916; e-mail:wfh@wfh.org
27. Report on the WFH Global Survey 2002. World Federation of Hemophilia, Montréal, Canada. 2002. This and previous year's surveys can be ordered from WFH headquarters at 1425 René Lévesque Boulevard West, Suite 1010, Montréal, Québec, H3G 1T7, Canada. Tel.: +1 (514) 875-7944; fax: +1 (514)